Immunovant, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.77 | -100% | -191071.59 | -100% |
| P/S |
|
0 | 33.76 | -100% |
|
|
| P/BV |
|
7.03 | 4.82 | 45.75% |
|
|
| P/FCF |
|
-12.49 | 61 | -120.47% |
|
|
| Ev/Ebitda |
|
-13.72 | -22.15 | -38.04% |
|
|
| Ev/S |
|
0 | 22.56 | -100% |
|
|
| Ev/FCF |
|
-17.27 | 68.78 | -125.11% |
|
|
| E/P |
|
-0.0968 | 0.0178 | -644.63% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
0 | 4.98 | -100% | 0 | 0% |
| ROE |
|
-52.91 | 9.61 | -650.5% |
|
|
| ROA |
|
-48.37 | 0.3443 | -14151.73% |
|
|
| ROIC |
|
-29.76 | 7.63 | -489.82% |
|
|
| ROS |
|
0 | -25.17 | -100% |
|
|
| ROCE |
|
-43.74 | 15.35 | -384.95% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.000511 | -3.68 | -99.99% | -0.0108 | -95.25% |
| Nеt Debt/Ebitda |
|
2.35 | -3.44 | -168.46% |
|
|
| Debt/Ratio |
|
0.000207 | 0.1985 | -99.9% |
|
|
| Debt/Equity |
|
0.4144 | 1.66 | -75.07% |
|
|
| Debt/Net Income |
|
-0.000532 | 10.32 | -100.01% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5442 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2237 | -100% |
|
|
| Average dividend growth |
|
0 | 0.9889 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4952 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5442 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
0 | -56.89 | -100% | ||
| Growth impulse Ebitda in 5 years |
|
311.55 | -54.68 | -669.77% | ||
| Growth impulse Net Income in 5 years |
|
290.57 | -58.33 | -598.15% | ||
| Growth impulse FCF in 5 years |
|
301.85 | -49.48 | -710.04% | ||
| Growth impulse EPS in 5 years |
|
21.94 | -32.41 | -167.7% |
IP Score
3.6/10
